Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 25 (2014), Issue 5, Pages 271-276
http://dx.doi.org/10.1155/2014/214813
Original Article

Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy

Lalit Saini,1 Jack T Seki,2,3 Deepali Kumar,4,5 Eshetu G Atenafu,6 David EC Cole,7,8 Betty YL Wong,8 Andrea Božović,9,10 and Joseph M Brandwein1

1Division of Hematology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
2Department of Pharmacy, Princess Margaret Cancer Centre, Canada
3Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
4Transplant Infectious Diseases, Alberta Transplant Institute, Canada
5University of Alberta, Edmonton, Alberta Transplant Institute, Canada
6Biostatistics Department, Princess Margaret Cancer Centre, Canada
7Department of Laboratory Medicine and Pathophysiology and Department of Clinical Pathology, University of Toronto, Canada
8Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Canada
9Laboratory Medicine Program, Toronto General Hospital, University Health Network, Canada
10Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

Copyright © 2014 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Lalit Saini, Jack T Seki, Deepali Kumar, et al., “Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 25, no. 5, pp. 271-276, 2014. doi:10.1155/2014/214813